Comparing Nutex Health (NASDAQ:NUTX) & MoneyHero (NASDAQ:MNY)

MoneyHero (NASDAQ:MNYGet Free Report) and Nutex Health (NASDAQ:NUTXGet Free Report) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Institutional & Insider Ownership

30.9% of MoneyHero shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 19.2% of MoneyHero shares are owned by insiders. Comparatively, 38.5% of Nutex Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares MoneyHero and Nutex Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MoneyHero -141.71% -417.43% -133.92%
Nutex Health -13.73% -43.79% -8.89%

Risk and Volatility

MoneyHero has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for MoneyHero and Nutex Health, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MoneyHero 0 0 0 0 N/A
Nutex Health 0 0 2 0 3.00

Nutex Health has a consensus target price of $45.00, indicating a potential upside of 130.77%. Given Nutex Health’s higher possible upside, analysts clearly believe Nutex Health is more favorable than MoneyHero.

Earnings & Valuation

This table compares MoneyHero and Nutex Health”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MoneyHero $88.97 million 0.48 -$172.60 million ($4.72) -0.23
Nutex Health $275.93 million 0.35 -$45.79 million ($10.59) -1.84

Nutex Health has higher revenue and earnings than MoneyHero. Nutex Health is trading at a lower price-to-earnings ratio than MoneyHero, indicating that it is currently the more affordable of the two stocks.

Summary

Nutex Health beats MoneyHero on 8 of the 13 factors compared between the two stocks.

About MoneyHero

(Get Free Report)

MoneyHero Limited operates as a personal finance company. It engages in operation of online financial comparison platforms and related services. The company offers its products under Money Hero, SingSaver, Money101, MoneyMax, CompareHero, Seedly, and Creatory brands. MoneyHero Limited operates in Singapore, Hong Kong, Taiwan, the Philippines, Malaysia, and Thailand. The company was founded in 2014 and is headquartered in Singapore.

About Nutex Health

(Get Free Report)

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

Receive News & Ratings for MoneyHero Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MoneyHero and related companies with MarketBeat.com's FREE daily email newsletter.